Financials
- Market Capitalization 951.69 M
- Employee 93
- Founded 2011
- CEO N/A
- Website www.annexonbio.com
- Headquarter Delaware, United States
- FIGI BBG007QVDFG2
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.75
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2458 | IMMX Immix Biopharma, Inc. - Common Stock | 13.93 USD | -2.66% | +1.75% | +64.46% | +505.65% | 996.54 M USD | ||
| 2466 | GERN Geron Corporation - Common Stock | 1.51 USD | -1.31% | -3.82% | +4.86% | +4.86% | 970.13 M USD | ||
| 2490 | ARDX Ardelyx, Inc. - Common Stock | 3.76 USD | -1.57% | -4.57% | -25.69% | -41.25% | 936.95 M USD | ||
| 2492 | DSGN Design Therapeutics, Inc. - Common Stock | 15.14 USD | -0.72% | -2.20% | +26.80% | +167.96% | 947.49 M USD |